乳腺癌新辅助化疗后疗效的预测:多种成像方式的比较  

Prediction of efficacy of neoadjuvant chemotherapy for breast cancer:a comparison of multiple imaging modalities

作　　者：孙德正 董文彦 方敏[1] 沈浮 刘超乾 盛湲[1] SUN Dezheng;DONG Wenyan;FANG Min;SHEN Fu;LIU Chaoqian;SHENG Yuan(Department of Thyroid and Breast Surgery,The First Affiliated Hospital of Naval Medical University(Second Military Medical University),Shanghai 200433,China;Department of Radiology,The First Affiliated Hospital of Naval Medical University(Second Military Medical University),Shanghai 200433,China)

机构地区：[1]海军军医大学(第二军医大学)第一附属医院甲乳外科,上海200433 [2]海军军医大学(第二军医大学)第一附属医院影像科,上海200433

出　　处：《海军军医大学学报》2025年第4期524-529,共6页Academic Journal of Naval Medical University

摘　　要：影像学检查在预测乳腺癌新辅助化疗后疗效中起到了重要作用,且不同的成像方式有各自的优势和价值。本综述对比了乳腺X线摄影、MRI、超声、正电子发射断层扫描在乳腺癌新辅助化疗后疗效方面的预测性能。MRI特别是动态增强MRI及影像组学和人工智能的结合显示出较高的灵敏性和特异性,逐渐成为了首选检查方式。随着技术的不断进步和研究的深入,这些成像方式有望在乳腺癌的精准治疗和个体化治疗中发挥更加重要的作用。Imaging modalities play an important role in predicting the efficacy of neoadjuvant chemotherapy for breast cancer,and different imaging modalities have their own advantages and value.In this review,the performance of mammography,magnetic resonance imaging(MRI),ultrasound,and positron emission tomography in predicting the efficacy of neoadjuvant chemotherapy for breast cancer was compared.Among them,MRI,especially dynamic contrast-enhanced MRI,and the combination of imaging omics and artificial intelligence,has shown high sensitivity and specificity,and has gradually become the preferred examination method.With the continuous progress of technology and research,these imaging modalities are expected to play more important roles in the precise and individualized treatment of breast cancer.

关 键 词：乳腺肿瘤 新辅助化疗 成像方式 参数指标 影像组学 人工智能 

分 类 号：R737.9[医药卫生—肿瘤]